Your browser is no longer supported. Please, upgrade your browser.
Settings
TTOO T2 Biosystems, Inc. daily Stock Chart
TTOO [NASD]
T2 Biosystems, Inc.
Index- P/E- EPS (ttm)-1.91 Insider Own0.10% Shs Outstand35.04M Perf Week3.75%
Market Cap145.42M Forward P/E- EPS next Y-1.63 Insider Trans4.47% Shs Float29.24M Perf Month2.47%
Income-58.80M PEG- EPS next Q-0.42 Inst Own59.90% Short Float5.37% Perf Quarter-9.78%
Sales3.90M P/S37.29 EPS this Y4.60% Inst Trans15.19% Short Ratio5.31 Perf Half Y18.57%
Book/sh0.58 P/B7.16 EPS next Y11.90% ROA-78.70% Target Price5.75 Perf Year-17.82%
Cash/sh1.51 P/C2.75 EPS next 5Y- ROE-245.40% 52W Range2.50 - 6.99 Perf YTD-21.10%
Dividend- P/FCF- EPS past 5Y- ROI-63.50% 52W High-40.63% Beta1.46
Dividend %- Quick Ratio5.30 Sales past 5Y- Gross Margin- 52W Low66.00% ATR0.20
Employees178 Current Ratio5.40 Sales Q/Q0.00% Oper. Margin- RSI (14)51.90 Volatility5.37% 5.04%
OptionableYes Debt/Eq2.29 EPS Q/Q12.30% Profit Margin- Rel Volume1.22 Prev Close4.26
ShortableYes LT Debt/Eq2.22 EarningsNov 02 AMC Payout- Avg Volume295.87K Price4.15
Recom2.00 SMA201.11% SMA501.07% SMA2000.44% Volume360,889 Change-2.58%
Oct-18-17Initiated H.C. Wainwright Buy $8
Mar-15-17Downgrade Morgan Stanley Equal-Weight → Underweight
Nov-10-16Resumed Leerink Partners Mkt Perform $5
Nov-02-16Reiterated Cantor Fitzgerald Buy $10 → $9
Jul-20-16Upgrade WBB Securities Buy → Strong Buy $11 → $12
Jun-22-16Upgrade WBB Securities Speculative Buy → Buy $11
Apr-12-16Reiterated Canaccord Genuity Buy $13 → $12
Feb-17-16Initiated WBB Securities Speculative Buy $11
Feb-10-16Initiated Cantor Fitzgerald Buy $15
Nov-27-17 08:00AM  T2 Biosystems to Attend the Global Mizuho Investor Conference GlobeNewswire
Nov-20-17 09:26AM  T2 Biosystems Announces New T2Bacteria RUO Panel Data Presented at AMP 2017 GlobeNewswire
Nov-09-17 08:00AM  T2 Biosystems Announces Presentation on T2Sepsis Solution at AMP 2017 GlobeNewswire
Nov-08-17 06:39PM  ETFs with exposure to T2 Biosystems, Inc. : November 8, 2017 Capital Cube
Nov-07-17 08:12AM  T2 Biosystems, Inc. :TTOO-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017 Capital Cube
Nov-06-17 04:48PM  Edited Transcript of TTOO earnings conference call or presentation 2-Nov-17 8:30pm GMT Thomson Reuters StreetEvents
Nov-02-17 06:54PM  T2 Biosystems reports 3Q loss Associated Press
04:05PM  T2 Biosystems Reports Third Quarter 2017 Financial Results and Provides Company Update GlobeNewswire
11:30AM  T2 Biosystems, Inc. to Host Earnings Call ACCESSWIRE
Nov-01-17 08:01AM  T2 Biosystems to Attend the Canaccord Medical Technologies and Diagnostics Forum GlobeNewswire
Oct-16-17 08:00AM  T2 Biosystems Announces 2017 Third Quarter Financial and Operational Results Release and Conference Call Date GlobeNewswire
Oct-13-17 11:18AM  ETFs with exposure to T2 Biosystems, Inc. : October 13, 2017 Capital Cube
Oct-12-17 10:45AM  Clinicians Discuss Positive Impact of T2MR Platform on Sepsis Care at IDWeek 2017 GlobeNewswire
Oct-03-17 07:00AM  Study Published in Journal of Antimicrobial Stewardship Shows Patients Diagnosed with T2Candida Panel Treated More Than Eight Times Faster GlobeNewswire
Sep-21-17 08:00AM  T2 Biosystems Announces Presentations at IDWeek 2017 GlobeNewswire
Sep-19-17 09:35AM  5 Medtech Stocks to Steer Clear of Amid Political Chaos Zacks
Sep-18-17 08:00AM  T2 Biosystems to Present at the Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
Sep-15-17 10:25AM  T2 Biosystems Prices Secondary Offering 24/7 Wall St. -25.66%
08:49AM  T2 Biosystems' stock sinks on heavy volume after share offering prices at deep discount MarketWatch
08:20AM  T2 Biosystems Announces Pricing of Public Offering of Common Stock GlobeNewswire
Sep-14-17 04:11PM  T2 Biosystems Announces Proposed Public Offering of Common Stock GlobeNewswire -10.32%
Sep-12-17 06:20PM  With FDA filing, Lexington firm targets a scourge of hospitals: sepsis American City Business Journals +8.29%
Sep-11-17 08:00AM  T2 Biosystems Submits 510(k) Application to the FDA for Review of T2Bacteria Panel GlobeNewswire +9.49%
Sep-06-17 07:05AM  T2 Biosystems and Cidara Therapeutics Announce Partnership for Commercial Placement of T2Dx Instruments to Support CD101 Drug Trials GlobeNewswire
07:00AM  T2 Biosystems Announces Collaboration with CDC to Detect Emerging Superbug Candida auris GlobeNewswire
Aug-31-17 09:46PM  ETFs with exposure to T2 Biosystems, Inc. : September 1, 2017 Capital Cube
Aug-30-17 08:00AM  T2 Biosystems Announces 11 New Patents Granted in 2017 GlobeNewswire
Aug-24-17 11:24AM  T2 Biosystems, Inc. :TTOO-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017 Capital Cube
Aug-15-17 10:18AM  T2 Biosystems and Aridis Pharmaceuticals, Inc. Join Antimicrobials Working Group PR Newswire +5.88%
Aug-11-17 11:51PM  Edited Transcript of TTOO earnings conference call or presentation 3-Aug-17 8:30pm GMT Thomson Reuters StreetEvents +6.51%
Aug-04-17 08:13PM  T2 Biosystems reports 2Q loss Associated Press +15.50%
Aug-03-17 04:05PM  T2 Biosystems Reports Second Quarter 2017 Financial Results; Provides Company Update GlobeNewswire
12:10PM  Investor Network: T2 Biosystems, Inc. to Host Earnings Call ACCESSWIRE
Aug-02-17 08:00AM  T2 Biosystems to Present at the 37th Annual Canaccord Genuity Growth Conference GlobeNewswire
Jul-27-17 08:58AM  T2 Biosystems Joins Antimicrobials Working Group as First Diagnostic Member GlobeNewswire
Jul-20-17 08:00AM  T2 Biosystems Announces 2017 Second Quarter Financial and Operational Results Release and Conference Call Date GlobeNewswire
Jul-18-17 08:00AM  T2 BIOSYSTEMS RECEIVES CE MARK FOR T2BACTERIA PANEL ENABLING COMMERCIALIZATION IN EUROPE GlobeNewswire +12.41%
Jul-13-17 04:48PM  ETFs with exposure to T2 Biosystems, Inc. : July 13, 2017 Capital Cube
Jun-19-17 08:00AM  T2 Biosystems Chief Scientific Officer Tom Lowery to Present at BIO 2017 Convention GlobeNewswire
Jun-08-17 08:00AM  T2 Biosystems to Present at the 2017 Marcum Microcap Conference GlobeNewswire
Jun-07-17 08:00AM  T2 Biosystems Announces New T2Sepsis Solution Clinical and Economic Results Presented by Leading Experts at ASM Microbe 2017 Conference GlobeNewswire
Jun-01-17 10:00AM  Study Published in the Journal of Clinical Microbiology Highlights Detection of Lyme Disease-Causing Bactera in Blood Using T2 Biosystems T2MR® Technology GlobeNewswire +12.39%
May-30-17 08:00AM  T2 Biosystems to Present at the Jefferies 2017 Global Healthcare Conference GlobeNewswire
May-25-17 12:50PM  ETFs with exposure to T2 Biosystems, Inc. : May 25, 2017 Capital Cube
May-24-17 08:00AM  T2 Biosystems Announces Presentations at ASM Microbe 2017 Conference GlobeNewswire
May-19-17 07:30AM  Henry Ford Health System to Present Webinar on Positive Clinical Impact of T2 Biosystems T2Candida® Panel GlobeNewswire
May-11-17 05:39PM  ETFs with exposure to T2 Biosystems, Inc. : May 11, 2017 Capital Cube
May-10-17 10:29AM  T2 Biosystems, Inc. :TTOO-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017 Capital Cube
May-04-17 02:10PM  Edited Transcript of TTOO earnings conference call or presentation 2-May-17 8:30pm GMT Thomson Reuters StreetEvents
May-02-17 06:00PM  T2 Biosystems reports 1Q loss Associated Press
04:01PM  T2 Biosystems Reports First Quarter 2017 Results and Corporate Update GlobeNewswire
08:15AM  Investor Network: T2 Biosystems, Inc. to Host Earnings Call Accesswire
May-01-17 09:00AM  T2 Biosystems Names Darlene Deptula-Hicks as Chief Financial Officer GlobeNewswire
Apr-25-17 03:51PM  ETFs with exposure to T2 Biosystems, Inc. : April 25, 2017 Capital Cube
Apr-24-17 07:54AM  T2 Biosystems Announces 2017 First Quarter Financial and Operational Results Release and Conference Call Date GlobeNewswire
Apr-19-17 09:04AM  T2 Biosystems to Host Symposium at 27th European Congress of Clinical Microbiology and Infectious Diseases GlobeNewswire
Apr-05-17 05:37PM  ETFs with exposure to T2 Biosystems, Inc. : April 5, 2017 Capital Cube
Mar-28-17 06:30AM  T2 Biosystems to Present at the Needham Healthcare Conference GlobeNewswire
Mar-24-17 01:04PM  T2 BIOSYSTEMS, INC. Financials
09:30AM  Zacks Industry Outlook Highlights: Varian Medical Systems, T2 Biosystems, Edwards Lifesciences, INSYS Therapeutics and Cerner Zacks
Mar-21-17 11:30AM  T2 Biosystems, Inc. :TTOO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017 Capital Cube
09:54AM  T2 Biosystems, Inc. :TTOO-US: Earnings Analysis: 2016 By the Numbers : March 21, 2017
Mar-15-17 05:27PM  T2 BIOSYSTEMS, INC. Files SEC form 10-K, Annual Report
06:08AM  T2 Biosystems downgraded by Morgan Stanley
Mar-08-17 04:12PM  T2 BIOSYSTEMS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Princip
Mar-03-17 12:24PM  T2 BIOSYSTEMS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Feb-16-17 06:06AM  T2 BIOSYSTEMS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib +8.35%
Feb-13-17 08:12PM  Edited Transcript of TTOO earnings conference call or presentation 13-Feb-17 9:30pm GMT Thomson Reuters StreetEvents
04:01PM  T2 Biosystems Reports Fourth Quarter and Full-Year 2016 Results GlobeNewswire
07:07AM  Q4 2016 T2 Biosystems Inc Earnings Release - After Market Close
Feb-06-17 06:30AM  T2 Biosystems to Present at the Leerink Global Healthcare Conference GlobeNewswire
Feb-03-17 06:30AM  T2 Biosystems Announces 2016 Fourth Quarter and Full-Year Results Release and Conference Call Date GlobeNewswire
Jan-30-17 06:30AM  Study Published in the American Journal of Clinical Pathology Highlights Rapid Detection of Platelet Function Using T2MR® Technology GlobeNewswire
Jan-25-17 06:30AM  T2 Biosystems to Host Webinar on the Vital Role of Transformative Diagnostics in Optimizing Antimicrobial Stewardship GlobeNewswire +6.01%
Jan-20-17 04:02PM  T2 BIOSYSTEMS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Jan-11-17 09:11AM  T2 BIOSYSTEMS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
Jan-09-17 06:30AM  T2 Biosystems Reports Preliminary Fourth Quarter Results and Operational Progress GlobeNewswire
Jan-06-17 04:06PM  T2 BIOSYSTEMS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definit
Jan-05-17 06:30AM  T2 Biosystems, Inc. Announces $50M Credit Facility GlobeNewswire
Dec-23-16 01:26PM  5 Stocks Poised for Major Breakouts +10.92%
Dec-20-16 12:59PM  Should You Buy T2 Biosystems Inc (TTOO)? at Insider Monkey
Dec-19-16 12:10PM  ETFs with exposure to T2 Biosystems, Inc. : December 19, 2016 +7.32%
Dec-08-16 01:07PM  ETFs with exposure to T2 Biosystems, Inc. : December 8, 2016
Nov-11-16 06:30AM  T2 Biosystems to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum GlobeNewswire +5.19%
Nov-08-16 05:06PM  T2 BIOSYSTEMS, INC. Files SEC form 10-Q, Quarterly Report
Nov-04-16 02:56PM  T2 BIOSYSTEMS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib +5.68%
Nov-03-16 04:45PM  T2 BIOSYSTEMS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statement -8.49%
04:01PM  T2 Biosystems Announces New Data at IDWeek 2016 GlobeNewswire
10:50AM  T2 Biosystems, Inc. :TTOO-US: Earnings Analysis: Q3, 2016 By the Numbers : November 3, 2016
Nov-01-16 11:52PM  Edited Transcript of TTOO earnings conference call or presentation 1-Nov-16 8:30pm GMT
06:31PM  T2 Biosystems reports 3Q loss
04:05PM  T2 Biosystems Reports Third Quarter Results GlobeNewswire
04:01PM  T2 Biosystems Announces Collaboration with Allergan to Develop the First Blood-Based Diagnostic Panel to Detect Antimicrobial Resistance GlobeNewswire
12:34PM  ETFs with exposure to T2 Biosystems, Inc. : November 1, 2016
07:07AM  Q3 2016 T2 Biosystems Inc Earnings Release - After Market Close
Oct-20-16 06:30AM  T2 Biosystems Announces 2016 Third Quarter and Nine-Month Results Release and Conference Call Date GlobeNewswire
Oct-13-16 08:00AM  T2 Biosystems Announces Presentations at IDWeek 2016 GlobeNewswire
Sep-23-16 01:10PM  Canon acquires 20% stake in Lexington diagnostics firm at bizjournals.com +5.90%
Sep-22-16 12:29PM  T2 BIOSYSTEMS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Secur +14.77%
08:00AM  T2 Biosystems Announces $40 Million Equity Investment by Partner Canon U.S.A. GlobeNewswire
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States. It provides T2 Magnetic Resonance platform that enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, and urine. The company also offers T2Dx, a bench-top instrument for sepsis, Lyme disease, and other applications, as well as T2Candida panel for the detection of candida species in human whole blood specimens. In addition, it is developing T2Bacteria, a multiplex diagnostic panel that detects various bacterial pathogens associated with sepsis; T2Lyme for the detection of various strains of Lyme disease-causing bacteria; and T2Plex, an integrated instrument for hemostasis applications, as well as T2HemoStat panel, a panel of diagnostic tests that can provide data across the hemostasis spectrum, including measurements of fibrinogen, platelet activity, and clot lysis. The company has collaboration agreement with Canon U.S. Life Sciences, Inc. to develop a novel diagnostic test panel to detect Lyme disease, a tick-borne illness; and Allergan Sales, LLC for the direct detection diagnostic test panel that adds additional bacteria species to the existing T2Bacteria product candidate and testing drug resistance directly in whole blood. T2 Biosystems, Inc. was founded in 2006 and is headquartered in Lexington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Elsbree David BDirectorNov 16Buy4.111,5006,1655,775Nov 17 02:33 PM
McDonough JohnPresident and CEOJun 06Option Exercise1.5050,00075,172247,353Jun 08 04:15 PM
Dhanda RahulSVP of Corporate DevelopmentJun 06Option Exercise0.483,0001,4404,667Jun 08 04:15 PM
Lapidus StanleyDirectorJun 06Option Exercise1.1620,00023,20020,000Jun 08 04:15 PM
Lowery Thomas J.Chief Scientific OfficerJun 06Option Exercise1.164,0004,64010,411Jun 08 04:15 PM
Cima Michael J.DirectorJun 06Option Exercise1.965,0009,800189,418Jun 08 04:15 PM
Elsbree David BDirectorJun 06Buy3.5010,00035,00050,000Jun 08 04:15 PM
Gibbs Michael TerrenceGeneral CounselJun 06Buy3.511,0003,51010,431Jun 08 04:15 PM
Dhanda RahulSVP of Corporate DevelopmentJun 06Buy3.501,0003,5005,667Jun 08 04:15 PM
Spadoro JoanneChief Operations OfficerJun 06Buy3.505,00017,5005,589Jun 08 04:15 PM
DEPTULA-HICKS DARLENE MSVP & Chief Financial OfficerJun 06Buy3.584,00014,3204,000Jun 08 04:15 PM
Elsbree David BDirectorMar 15Buy5.9710,00059,70040,000Mar 17 11:56 AM